Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.30 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.30 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2142720 | 0.88 | DNM1 (0.36) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3847063 | 0.85 | ADRB2 (0.39) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL5072109 | 0.82 | DNM1 (0.40) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL483477 | 0.78 | DNM1 (0.33) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL18789392 | 0.76 | THRB (0.40) | TSHRMEN1KMT2ACA1CA2 | |
| SCHEMBL5072153 | 0.73 | — | — | |
| SCHEMBL2140022 | 0.72 | OPRM1 (0.46) | ADRB2ADRB1ADRB3 | |
| SCHEMBL5070092 | 0.71 | DNM1 (0.38) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL18528716 | 0.70 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Butylamine SCHEMBL3495997 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796411-B2 | Polyimide precursor composition, polyimide film, and transparent flexible film | HITACHI CHEMICAL DUPONT MICROSYSTEMS, LTD. (JP) | 2014-08-05 | — | — | US | disclosed |
| US-8257611-B2 | Optical film and retardation sheet, and liquid crystal compound | FUJIFILM CORPORATION (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20110059305-A1 | POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE FILM, AND TRANSPARENT FLEXIBLE FILM | HITACHI CHEMICAL DUPONT MICROSYSTEMS, LTD. (JP) | 2011-03-10 | — | — | US | disclosed |
| EP-2248843-A1 | POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE FILM AND TRANSPARENT FLEXIBLE FILM | Hitachi Chemical DuPont Microsystems, Ltd. (JP) | 2010-11-10 | — | — | EP | disclosed |
| US-20100045901-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| WO-2008072794-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2008-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100045901-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | C1R, CCNA1, C5 | DNM1 1602/4885TSHR 729/4885MEN1 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.